treatment naïve
Showing 1 - 25 of 6,080
Myelofibrosis, Moderate Thrombocytopenia Trial (Selinexor)
Not yet recruiting
- Myelofibrosis
- Moderate Thrombocytopenia
- (no location specified)
Jul 31, 2023
Non-Muscle- Invasive Bladder Cancer Trial (Durvalumab, BCG)
Not yet recruiting
- Non-Muscle- Invasive Bladder Cancer
- Durvalumab
- BCG
- (no location specified)
Jul 5, 2023
Lung Cancer, NSCLC, Brain Metastases Trial (Alectinib, Stereotactic Radiosurgery)
Not yet recruiting
- Lung Cancer
- +2 more
- Alectinib
- Stereotactic Radiosurgery
- (no location specified)
Aug 4, 2023
HIV-1-infection Trial (Low-dose STP0404 (Pirmitegravir), Medium-dose STP0404 (Pirmitegravir), High-dose STP0404 (Pirmitegravir))
Not yet recruiting
- HIV-1-infection
- Low-dose STP0404 (Pirmitegravir)
- +3 more
- (no location specified)
May 16, 2023
Twin Vaginal Delivery Skills Trial in Pescara (twin vaginal delivery simulation)
Recruiting
- Twin Vaginal Delivery Skills
- twin vaginal delivery simulation
-
Pescara, Italia, ItalyClaudio Celentano
Nov 6, 2023
Vitamin D Deficiency, Peripheral Neuropathy Trial (Vitamin D)
Not yet recruiting
- Vitamin D Deficiency
- Peripheral Neuropathy
- Vitamin D
- (no location specified)
May 2, 2023
Prostate Cancer Trial in Taoyuan (Multiparametric magnetic resonance imaging (mpMRI))
Active, not recruiting
- Prostate Cancer
- Multiparametric magnetic resonance imaging (mpMRI)
-
Taoyuan, TaiwanLi-Jen Wang
Nov 9, 2023
Merkel Cell Carcinoma Trial in Milano, Siena, Verona (Pembrolizumab, Etoposide, Cisplatin or Carboplatin)
Not yet recruiting
- Merkel Cell Carcinoma
- Pembrolizumab, Etoposide, Cisplatin or Carboplatin
-
Milano, Italy
- +2 more
Oct 10, 2023
The First Affiliated Hospital of Nanchang University Trial in Nanchang, Jinan (Orelabrutinib+R-CHOP)
Recruiting
- The First Affiliated Hospital of Nanchang University
-
Nanchang, Jiangxi, China
- +1 more
Jul 3, 2023
Healthy Volunteers Trial in Philadelphia (INO-A002, CELLECTRA® 2000, Dengue Fever Antibodies (IgG))
Completed
- Healthy Volunteers
- INO-A002
- +2 more
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Nov 7, 2022
IBD Trial in Paris (Biocollection)
Not yet recruiting
- Inflammatory Bowel Diseases
- Biocollection
-
Paris, FranceSaint Antoine Hospital Service de Gastroentérologie et Nutrition
Feb 1, 2023
Sinus Rhythm Mapping in Pulmonary Vein Isolation Naive Atrial
Recruiting
- Atrial Fibrillation
- AI-enabled ECG score for Atrial Fibrillation (DNN score)
- Atrial voltage map in sinus rhythm
-
Genk, Limburg, BelgiumZiekenhuis Oost-Limburg
Oct 19, 2023
Diabetic Macular Edema, Pars Plana Vitrectomy, Conbercept Trial in Tianjin (Vitrectomy combined with ILM peeling, Conbercept
Not yet recruiting
- Diabetic Macular Edema
- +2 more
- Vitrectomy combined with ILM peeling
- Conbercept intravitreal injection
-
Tianjin, Tianjin, ChinaTianjin medical university eye hosipital
Feb 14, 2023
HIV Positive Trial in Saint-etienne (blood and urinary samples)
Not yet recruiting
- HIV Positive
- blood and urinary samples
-
Saint-etienne, FranceChu Saint-Etienne
Nov 29, 2022
Whipworm, Trichuriasis, Controlled Human Infection Trial in Washington, Bethesda (Trichuris trichiura Egg Inoculum)
Not yet recruiting
- Whipworm
- +2 more
- Trichuris trichiura Egg Inoculum
-
Washington, District of Columbia
- +1 more
Jan 20, 2023
OCD Trial in Shanghai (high-definition transcranial direct current stimulation, Sham tDCS)
Recruiting
- Obsessive-Compulsive Disorder
- high-definition transcranial direct current stimulation
- Sham tDCS
-
Shanghai, Shanghai, ChinaShanghai Mental Health Center
Sep 7, 2022
Paroxysmal Nocturnal Hemoglobinuria Treated With Anti-C5
Completed
- Paroxysmal Nocturnal Hemoglobinuria
- Anti-C5 antibody treatment
-
Paris, FranceAP-HP Hôpital Saint Louis
Apr 24, 2023
Hiv, HIV-1-infection Trial in Buenos Aires (Lamivudine 300 MG, Emtricitabine / Tenofovir Disoproxil Pill)
Active, not recruiting
- Hiv
- HIV-1-infection
- Lamivudine 300 MG
- Emtricitabine / Tenofovir Disoproxil Pill
-
Buenos Aires, ArgentinaFundacion IDEAA
Jan 2, 2023
NSCLC Trial (Lazertinib group)
Not yet recruiting
- NSCLC
- Lazertinib group
- (no location specified)
Jul 14, 2022
NSCLC, Lung Diseases, Lung Tumors Trial in New Haven (Sitravatinib, Pembrolizumab)
Recruiting
- Carcinoma, Non-Small-Cell Lung
- +8 more
-
New Haven, ConnecticutYale University
Oct 26, 2022
Diffuse Large B Cell Lymphoma Trial in Shanghai (Zanubrutinib, Polatuzumab Vedotin, Rituximab)
Recruiting
- Diffuse Large B Cell Lymphoma
- Zanubrutinib, Polatuzumab Vedotin, Rituximab
-
Shanghai, Shanghai, ChinaZhongshan Hospital,Fudan University
Jul 10, 2023